Oncology

Research is fundamental for cancer programs, and resuming clinical oncology trials is vital to ensure patients maintain access to potentially life-saving treatments.

Cancer providers must prepare to care for pent-up volumes while simultaneously ensuring their operations and facilities remain safe for patients and staff.

Survivors of laryngeal and bladder cancer face an increased risk of developing a secondary cancer compared to the general population, according to a large study published in JAMA Network Dec. 22. 

Brunswick, N.J.-based Rutgers Cancer Institute received an anonymous $25 million donation that will support its Cancer Immunology and Metabolism Center of Excellence. 

Memorial Sloan Kettering Cancer Center has paid more than $1.5 million in severance to its former CMO, who resigned in 2018 after he did not disclose financial ties to healthcare companies in research papers he authored, according to The New…

Adekunle "Kunle" Odunsi, MD, PhD, was selected as director of UChicago Medicine Comprehensive Cancer Center effective March 1, 2021. 

Cleveland Clinic will conduct a clinical trial for a breast cancer vaccine by spring 2021, reports Cleveland's Fox 8 News. 

Philips plans to purchase a remote cardiac diagnostics and monitoring technology company for $2.8 billion.

Breast cancer is now the leading cause of cancer worldwide, according to the International Agency for Research on Cancer's 2020 global estimates published Dec.15. 

The American Cancer Society anticipates a minimum $200 million budget shortfall, partially related to drops in donations, the organization told Becker's Dec. 15.